Literature DB >> 1991432

Role of diabetologist in evaluating diabetic retinopathy.

D M Nathan1, H A Fogel, J E Godine, P L Lou, D J D'Amico, C D Regan, T M Topping.   

Abstract

OBJECTIVE: To evaluate the ability of diabetologists to screen diabetic patients for diabetic retinopathy. RESEARCH DESIGN AND METHODS: Comparison of eye examination performed by diabetologists with direct ophthalmoscopy through an undilated pupil and by ophthalmologists through a dilated pupil with seven-field stereoscopic fundus photography (gold standard). The study consisted of 67 insulin-dependent and non-insulin-dependent diabetic outpatients attending a diabetes clinic.
RESULTS: On the basis of fundus photography, patients were classified as having no or insignificant (30%), minimal (31%), moderate (24%), or severe (15%) retinopathy. The diabetologists and ophthalmologists performed similarly in their ability to classify severity of diabetic retinopathy accurately. When no or insignificant retinopathy (isolated microaneurysms only) was detected by examination, clinically significant retinopathy detected by fundus photography was highly unlikely (less than 5%). On the other hand, if more than isolated microaneurysms were seen on examination, all examiners missed more severe lesions detected by fundus photography. Patients with corrected visual acuity worse than 20/30 had a high likelihood (100%) of moderate or severe retinopathy.
CONCLUSIONS: Motivated well-trained diabetologists can screen for diabetic retinopathy. The absence of detectable lesions by direct ophthalmoscopy indicates that automatic referral to an ophthalmologist is not necessary. However, if any level of retinopathy is detected or corrected acuity is worse than 20/30, referral to an ophthalmologist is required. In this setting, fundus photography is advised because it is the most sensitive means of detecting clinically significant retinopathy. If other nonophthalmologists can be trained to achieve similar results, current recommendations for ophthalmologic referral that require annual ophthalmologic examinations for most diabetic patients may need to be reconsidered.

Entities:  

Mesh:

Year:  1991        PMID: 1991432     DOI: 10.2337/diacare.14.1.26

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  6 in total

1.  Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema.

Authors:  Ingrid U Scott; Neil M Bressler; Susan B Bressler; David J Browning; Clement K Chan; Ronald P Danis; Matthew D Davis; Craig Kollman; Haijing Qin
Journal:  Retina       Date:  2008-01       Impact factor: 4.256

2.  The retinal disease screening study: prospective comparison of nonmydriatic fundus photography and optical coherence tomography for detection of retinal irregularities.

Authors:  Yanling Ouyang; Florian M Heussen; Pearse A Keane; Srinivas R Sadda; Alexander C Walsh
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-19       Impact factor: 4.799

3.  A diabetes control program in a public health care setting.

Authors:  S B Baker; C Vallbona; V Pavlik; C E Fasser; M Armbruster; R McCray; R L Baker
Journal:  Public Health Rep       Date:  1993 Sep-Oct       Impact factor: 2.792

4.  Use of mobile screening unit for diabetic retinopathy in rural and urban areas.

Authors:  G P Leese; S Ahmed; R W Newton; R T Jung; A Ellingford; P Baines; S Roxburgh; J Coleiro
Journal:  BMJ       Date:  1993-01-16

5.  SDOCT imaging to identify macular pathology in patients diagnosed with diabetic maculopathy by a digital photographic retinal screening programme.

Authors:  Sarah Mackenzie; Christian Schmermer; Amanda Charnley; Dawn Sim; Martin Dumskyj; Stephen Nussey; Catherine Egan
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

6.  Diabetic Retinopathy Screening Ratio Is Improved When Using a Digital, Nonmydriatic Fundus Camera Onsite in a Diabetes Outpatient Clinic.

Authors:  Pia Roser; Hannes Kalscheuer; Jan B Groener; Daniel Lehnhoff; Roman Klein; Gerd U Auffarth; Peter P Nawroth; Florian Schuett; Gottfried Rudofsky
Journal:  J Diabetes Res       Date:  2016-01-21       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.